E2 has been shown to inhibit death receptor-induced apoptosis in hepatoma cells, presumably through inhibition of mitochondrial cytochrome c release [129], and at the same time, it has been shown to induce mitochondria-related and caspase-dependent apoptosis in the same hepatoma cell line [137]. Here, CYCS is linked to hepatocellular carcinoma.